Meet the experts

Article

Come and visit the Bausch + Lomb Booth No 16 at the WOC in Berlin to meet the Experts and ask questions. Explore Q2, delivering Quantity and Quality of Vision with the revolutionary Crystalens HD?, the premium accommodating IOL that gives high definition vision at all distances.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Subscribe Now!
Recent Videos
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
Sheng Lim, MD, FRCOphth, brings data from the CONCEPT study to the ASCRS meeting
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
A panel discussion on extended treatment intervals in retinal therapy breaks the mold at COPHy 2025
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
How embracing opposition sends clinicians home from COPHy with more useful takeaways
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Angiogenesis 2025: The global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
Veterinary ophthalmology can foster insights and progress in glaucoma care
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
I. Paul Singh, MD, says artificial intelligence will help glaucoma specialists make decisions
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Charles Wykoff, MD, PhD, presents on diabetic retinopathy and "the dream of reperfusion" at Floretina ICOOR 2024
How a gene-agnostic approach opens doors to new therapeutics
How a gene-agnostic approach opens doors to new therapeutics
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
AAO 2024: Main takeaways from the Zoster Eye Disease study
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
AAO 2024: New data illuminate glaucoma care paradigms for surgical interventions
Related Content
UVC light can be used as a noninvasive treatment for microbial keratitis. Image courtesy of Photon Therapeutics. Concept image for cornea treatment with ultraviolet light.

The future of microbial keratitis treatment is bright

Priyanka Mandal, MBChB FRCOphth;Sunil Shah, MBBS, FRCS(Ed), FRCOphth, FBCLA, FWCRS
April 29th 2025
Article

Ultraviolet light’s potential in ocular care extends beyond structural reinforcement to antimicrobial applications, especially for microbial keratitis

Higher molar dose and its translation into clinical practice. Led by John Kitchens, MD; Joined by Peter Kaiser, MD

Higher Molar Dose and Its Translation into Clinical Practice

John Kitchens, MD;Peter Kaiser, MD
July 22nd 2024
Podcast
A woman in a surgical mask, covering her nose and mouth, rubs her eyes. Concept image for autoimmune disease correlation to dry eye disease. Image credit: ©Prostock-studio – stock.adobe.com

Diagnosing types of dry eye in patients with autoimmune disease

Lynda Charters
April 24th 2025
Article

A young boy with glasses reading a book. Concept image for atropine drop paediatric myopia treatment approval in India. Image credit: ©WESTOCK – stock.adobe.com

ENTOD Pharmaceuticals announces CDSCO approval of 0.05% atropine drops (Myatro XL)

Hattie Hayes;Emily Kaiser Maharjan;Jordana Joy
April 23rd 2025
Article

According to a press release, Myatro XL is the first 0.05% atropine eye drop for paediatric myopia control.

A red light with an alarm symbol. It reads "SOS." Concept image for emergency, medical emergency, neurology and ophthalmology referral. Image credit: ©Nicole Kwiatkowski – stock.adobe.com

Investigating causes of diplopia to minimise morbidity and mortality

Lynda Charters
April 23rd 2025
Article

Canadian investigators urged quick neuro-ophthalmologic referrals to limit the progress of life- and vision-threatening conditions

A photo of a boardroom with a presenter's projector screen, and easel, and many chairs. Concept image for Beth Marsh appointed CCO chief commercial officer of Neurotech Pharmaceuticals, ophthalmic industry news update. Image credit: ©nnpp's Images – canva.com

Neurotech appoints Beth Marsh as chief commercial officer ahead of US product launch

Kassi Filkins
April 22nd 2025
Article

The US FDA recently approved revakinagene taroretcel-lwey (ENCELTO) for the treatment of idiopathic macular telangiectasia type 2 (MacTel)

© 2025 MJH Life Sciences

All rights reserved.